Tag: K102
-
New MS remyelination drugs move closer to trials as K102 and K110 show promise in repairing nerve damage
Two experimental remyelination compounds, K102 and K110, are advancing toward clinical testing, raising hopes for therapies that repair myelin damage in MS.